Skip to Content

S 063 (Agrylin 0.5 mg)

Generic Name: anagrelide

Pill with imprint S 063 is White, Capsule-shape and has been identified as Agrylin 0.5 mg. It is supplied by Shire US Inc..

Agrylin is used in the treatment of thrombocythemia; chronic myelogenous leukemia and belongs to the drug class miscellaneous uncategorized agents. Risk cannot be ruled out during pregnancy. Agrylin 0.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for S 063

Agrylin

Generic Name:
anagrelide
Imprint:
S 063
Strength:
0.5 mg
Color:
White
Size:
14.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Miscellaneous uncategorized agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Shire US Inc.
Inactive Ingredients:
lactose anhydrous
crospovidone
lactose monohydrate
magnesium stearate
microcrystalline cellulose
povidone
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide